Catalyst Wire Dossier Catalyst Wire Dossier

AVGEMSI

GEMCITABINE · Avyxa Pharma, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVGEMSI, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: FDA Approved: AVGEMSI — Original Application (Avyxa Pharma, LLC)

See pricing